Kronos Bio, Inc. (KRON) Stock Analysis
DELISTED 2025
What happened to Kronos Bio, Inc. (KRON) stock?
Kronos Bio, Inc. (KRON) no longer trades on public markets. It was delisted in June 2025. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- June 2025
- Last recorded price (historical):
- $0.88 (last quote on record before the June 2025 delisting; historical, not a current quote)
Market cap $53.7M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Kronos Bio, Inc. (KRON). Kronos Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing novel cancer therapeutics by targeting dysregulated transcription factors.
Last analyzed: Jun 14, 2026Dated analysis: the newest financial statements on file are 25 months old (Sep 1, 2024), so the figures and score below describe that period, not today.
Kronos Bio, Inc. (KRON) Healthcare & Pipeline Overview
More about this archive record
Can I still buy KRON shares?
No. KRON stopped trading on public markets in June 2025, so the shares are not available through a broker. Anything you see quoted for KRON elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before KRON stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Kronos Bio, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.